Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oligonucleotide therapeutics: 25 years agrowing.

John Goodchild1

  • 1Worcester State College, Department of Chemistry, 486 Chandler Street, Worcester, MA 01602-2597, USA. jgoodchild1@worcester.edu

Current Opinion in Molecular Therapeutics
|June 16, 2004
PubMed
Summary

Antisense oligonucleotides offer a direct link from genomics to gene function and therapeutics. This review covers recent advances in oligonucleotide mechanisms, modifications, and applications, particularly in RNA inhibition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic oligonucleotides.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

A fight at the opera.

Current opinion in molecular therapeutics·2008
Same author

Oligonucleotide, antibody and peptide therapeutics--from design to the clinic.

Current opinion in molecular therapeutics·2004
Same author

Hammerhead ribozymes for target validation.

Expert opinion on therapeutic targets·2002

Area of Science:

  • Molecular Biology
  • Genomics
  • Drug Discovery

Background:

  • The 25th anniversary of antisense oligonucleotide research in cells was in 2003.
  • Oligonucleotides offer a bridge between genomics and understanding gene function.
  • They are crucial for drug target validation and developing new therapeutics.

Purpose of the Study:

  • To review recent advances in oligonucleotide mechanisms, chemical modifications, and applications.
  • To provide an overview of progress in the field, focusing on RNA inhibition.
  • To highlight the link between genomics and therapeutic development.

Main Methods:

  • Literature review of recent advances in oligonucleotide research.
  • Analysis of mechanisms, chemical modifications, and diverse applications.
  • Focus on RNA inhibition strategies.

Main Results:

  • Oligonucleotides complementary to RNA utilize various mechanisms for gene function analysis.
  • Applications extend to DNA and protein binding for similar purposes.
  • Significant progress has been made in RNA inhibition technologies.

Conclusions:

  • Antisense oligonucleotides are versatile tools linking genomics to therapeutic applications.
  • Ongoing research in chemical modifications and mechanisms enhances their utility.
  • Oligonucleotides represent a promising avenue for novel drug development.

Related Experiment Videos